Elderly patients with advanced non-small cell lung cancer: A phase II study with weekly cisplatin and gemcitabine

Oncology

Volumn 65, Issue 3, 2003, Pages 198-203

  Berardi, R ^a   Porfiri, E ^a   Scartozzi, M ^a   Lippe, P ^a   Silva, R R ^b   Nacciarriti, D ^b   Menichetti, E T ^b   Tummarello, D ^a   Carle, F ^a   Piga, A ^a   Cellerino, R ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Medical Oncology Unit   (Italy)

Author keywords

Cisplatin based chemotherapy; Elderly patients; Non small cell lung cancer

Indexed keywords

CISPLATIN; GEMCITABINE;

ADVANCED CANCER; AGED; AGING; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; PARESTHESIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0345600108     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074471     Document Type: Article

References (31)

1. Fry WA, Menk HR, Winchester DP: The National Cancer Data Base report on lung cancer. Cancer 1996;77:1947-1955.
2. Langer CJ, Manola J, Bernardo P, Kugler JW, Bonomi P, Cella D, Johnson DH: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002;94:173-181.
3. Lippe P, Tummarello D, Monterubbianesi MC, Silva RR, Giuliodori L, Mari D, Santo A, Pasini F, Cetto GL, Rossi D, Porfiri E, Cascinu S, Cellerino R: Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study. Ann Oncol 1999;10:217-221.
4. Vogl SE, Berenzweig M, Camacho F, Greenwald E, Kaplan BH: Efficacy study of intensive cisplatin therapy in advanced non-small cell bronchogenic carcinoma. Cancer 1982;50:24-26.
5. Gandara DR, DeGregorio MW, Wold H, Wilbur BJ, Kohler M, Lawrence HJ, Deisseroth AB, George CB: High-dose cisplatin in hypertonic saline: Reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer. J Clin Oncol 1986;4:1787-1793.
6. Shepherd FA, Cormier Y, Burkes R, Evans WK, Goss G, Klimo P, Feld R, Taylor M: Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer. Semin Oncol 1997;24(suppl 8):S27-S30.
7. Green MR, Eisenberg M, Kotsy L, Stolbach L, Hainsworth J, Zaknoen S: Activity and tolerability of gemcitabine plus weekly cisplatin in advanced non-small cell lung cancer. Proc ASCO 1998;17:1798A.
8. Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ: Interactions between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 1995;22:72-79.
9. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
10. Simon R: Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10: 1-10.
11. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-481.
12. Armitage P, Berry G: Survival analysis; in Statistical Methods in Medical Research, ed 3. Oxford, Blackwell Scientific, 1994, pp 469-492.
13. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
14. Grilli R, Oxman AD, Julian JA: Chemotherapy for advanced non-small cell lung cancer: How much benefit is enough? J Clin Oncol 1993;11: 1866-1872.
15. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E, Rapp E, Tummarello D, Williams J, Woods BL, Bernard JP: Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis. Lancet 1993;342:19-21.
16. Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, Nicholson M, Milroy R, Maughan TS, Falk SJ, Bond MG, Burt PA, Connolly CK, McIllmurray MB, Carmichael J: Gemcitabine plus best supportive care (BSC) vs. BSC in inoperable non-small cell lung cancer: A randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Br J Cancer 2000;83:447-453.
17. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J: Prospective randomized trial of doce-taxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000;18:2095-2103.
18. Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Bonifazi V, Orlandini C, Conte PF: A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma. Cancer 2000;89:1714-1719.
19. Gridelli C, Cingolari S, Gallo C, Manzione L, Ianniello GP, Frontini L, Ferrau F, Robbiati SF, Adamo V, Gasparini G, Novello S, Perrone F: Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer 2001;31:277-284.
20. Beretta GD, Michetti G, Belometti MO, Gritti G, Quadri A, Poletti P, Labianca R: Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer. Br J Cancer 2000;83:573-576.
21. The Elderly Lung Cancer Vinorelbine Italian Study Group: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 1999;91:66-72.
22. Altavilla G, Adamo V, Buemi B, Marabello G, Maisano R, Lupo G, Bene A, Bellocco G: Gemcitabine as single agent in the treatment of elderly patients with advanced non-small cell lung cancer. Anticancer Res 2000;20(5C): 3675-3678.
23. Buccheri G, Ferrigno D: Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: A phase II study. Cancer 2000;88: 2677-2685.
24. Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Algeri R, Bonifazi V, Fioretto ML, Orlandini C, Conte PF: Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: A multicenter phase II study. Lung Cancer 2000;27:75-80.
25. Martoni A, Di Fabio F, Guaraldi M, Piana E, Ramini R, Lelli G, Palomba G, Artioli F, Bandieri E, Robustelli Della Cuna G, Preti P: Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer. Am J Clin Oncol 2001;24:614-617.
26. Hainsworth JD, Burris HA 3rd, Greco FA: Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer. Semin Oncol 2001; 28(3 suppl 9):21-25.
27. Fidias P, Supko JG, Martins R, Boral A, Carey R, Grossbard M, Shapiro G, Ostler P, Lucca J, Johnson BE, Skarin A, Lynch TJ: A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res 2001;7:3942-3949.
28. Frasci G, Lorusso V, Panza N, Comella P, Nicolella G, Bianco A, De Cataldis G, Iannelli A, Bilancia D, Belli M, Massidda B, Piantedosi F, Comella G, De Lena M: Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18:2529-2536.
29. Gridelli C, Perrone F, Cigolari S, Manzione L, Piantedosi FV, Barbera S, Piazza E, Vinante O, Clerici M, Robbiati F, Bertetto O, Frontini L, Sacco C, Iaffaioli RV, Gallo C: The MILES (Multicenter Italian Lung Cancer in the Elderly Study) phase III trial: Gemcitabine and vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced non-small cell lung cancer. Proc ASCO 2001;308A.
30. Martins SJ, Pereira JR, Ikari FK, Nikaedo SM, Gampel O: Chemotherapy with cisplatin and vinorelbine for elderly non-small cell lung cancer patients. Proc ASCO 1999;1804A.
31. Feliu J, Martin G, Rodriguez-Jaraiz MA, Madronal C, De Castro J, Rodriguez A, Bolano M, Checa T, Espinosa E, Torrego J, Gonzalez Baron M: Phase II trial of low dose cisplatin plus gemcitabine in elderly patients with advanced non-small cell lung cancer: Preliminary results. Proc ASCO 2001;2763A.